The George Washington University School of Medicine and Health Sciences is the professional medical school of the George Washington University, in Washington, D.C. SMHS is one of the most selective medical schools in the United States based on the number of applicants.

During the past decade, George Washington University School of Medicine and Health Sciences conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "George Washington University School of Medicine and Health Sciences" #1 sponsor was "George Washington University" with 3 trials, followed by "Andrea Gropman" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Celldex Therapeutics" with 1 trials sponsored and "Regeneron Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "George Washington University School of Medicine and Health Sciences" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Makerere University" with 1 trials as a collaborator, "National Center for Research Resources (NCRR)" with 1 trials as a collaborator, "National Institute on Minority Health and Health Disparities (NIMHD)" with 1 trials as a collaborator and "Office of Rare Diseases (ORD)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "George Washington University School of Medicine and Health Sciences" are "Brain Diseases, Metabolic, Inborn" (1 trials), "Colorectal Cancer (CRC)-Enrollment Completed" (1 trials), "Cutaneous Squamous Cell Carcinoma" (1 trials), "Dermatitis, Atopic" (1 trials) and "Diarrhea" (1 trials). Many other conditions were trialed in "George Washington University School of Medicine and Health Sciences" in a lesser frequency.

Most popular intervention types in "George Washington University School of Medicine and Health Sciences" are "Drug" (5 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "CC-93538" (1 trials), "Cemiplimab" (1 trials), "Combination of varlilumab and nivolumab" (1 trials) and "GVHD Regimen A: UCB Recipients" (1 trials). Other intervention names were less common.

The vast majority of trials in "George Washington University School of Medicine and Health Sciences" are 8 trials for "All" genders.

Currently, there are NaN active trials in "George Washington University School of Medicine and Health Sciences". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in George Washington University School of Medicine and Health Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in George Washington University School of Medicine and Health Sciences, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".